A BBC radio presenter suffering health problems arising from a covid vaccine said she is disturbed at the media’s failure to tackle the issue.
“I think the media have been told to be quiet. I think it must be that. They don’t want to hear another side,” Kent Radio host Jules Serkin said.
A social media and marketing professional and former business columnist, Serkin received her first and only dose of AstraZeneca on March 5 2021. She has suffered ongoing issues since.
“I had the jab on March 5 (2021) and I’ve been ill ever since that very night,” she told GB News’ Mark Steyn in an interview.
The five minute clip on YouTube has racked up almost 60,000 views in two days, with 1,500 comments, many of which describe similar adverse reactions to covid injections.
Serkin speaks about what she calls ‘vax attacks’ – days of fatigue, ‘that come with no warning.’
“I’ve set up a small support group for vax damaged people, we are beginning to see a pattern now with these vax attacks where you get a day of fatigue but you carry on… And then in my case the pains start jabbing in the left eye. I’ve been having lots of eye problems; eye droop and facial numbness,” she said.
Serkin described how pain and fatigue have adversely affected her everyday life. She was unable to attend a recent family weekend away due to her ongoing health issues.
“We’d got a lovely hotel booked for a family weekend and .. I sat down on the stairs on Friday morning having packed my bag and my husband said ‘’you look awful’ and I said, ‘I can’t come.’”
“And it was just a big deal because I am a bit of a live wire and I love a party… pre AstraZeneca,” she said.
Asked if she was ‘disturbed’ by the lack of media coverage, Serkin replied ‘I am.’
“I sometimes scream at Jeremy Vine’s radio show because he is just so pro vax.
“I’ve certainly heard presenters shutting up people on the show when they are just giving another side, our side basically.
“My local paper wrote a story last May (2021) and the young journalist said keep us informed and they have never written anything else.
“I think the media have been told to be quiet. I think it must be that. They don’t want to hear another side,” she said.
From within her vaccine support group, Serkin said she gets messages ‘most days.’
“And all of our symptoms are similar…it’s nerve damage, people bed ridden for five or six months, it’s an endless list. And even in my everyday life; I was getting my nails done and the young girl there had Pfizer last year and said she hasn’t had her period since.
“So I am frustrated. I really am frustrated,” she said.
Many don’t have formal diagnosis yet they know it is caused by the “vaccine” many still trying to get treatment. https://t.co/RtnvWVEWRL
— jules serkin (@julesserkin) May 12, 2022
Serkin filed her experience on the Yellow Card scheme, the UK mechanism by which anybody can voluntarily report suspected vaccine adverse reactions. The Irish equivalent is the Health Product Regulatory Authority (HPRA) Covid 19 Vaccine Adverse Reaction Report
“I filled in the Yellow Card in April and then I also filled in the AstraZeneca form and that’s really frustrating because you just get these ridiculous emails back on some really old fashioned format that you can’t even read on a phone, you need to use the computer,” she said.
“My GP filled in a form to Astra Zeneca stating the long, long list of symptoms, the nerve damage and all the awful life changing symptoms I’ve had. She sent it last September 21 and has only ever received an auto-response.”
“I have phoned AZ twice and each phone call was frustrating and on the second call I just put down the phone in tears. They don’t care,” Serkin said.
At present, just under 20,000 reports of suspected Covid 19 side effects have been made to the HPRA in Ireland.
The latest figures from the HPRA Safety Update were published on March 24 2022, with a total of 19,869 reports of adverse reactions to all four Covid Vaccines.
Reports of reactions to the Astra Zeneca vaccine are grouped together with Janssen’s one shot vaccine, by the HPRA, with a total of 6,660 suspected cases of side effects – some with multiple symptoms – reported.
The HPRA figures are added to EudraVigilance – the European database of suspected adverse drug reaction reports operated by the European Medicines Agency.
The number of individual cases identified in EudraVigilance for AstraZeneca’s vaccine is 484,723, with 30% of these reported by a health care professional.
Ireland ceased deliveries of AstraZeneca and Janssen vaccines in August 2021. The reason given, according to RTÉ, was “to avoid any unnecessary build up and possible wastage of vaccines”.
The next HPRA Covid 19 vaccine safety update is to be published next week, May 19 2022.
The European Medicines Agency (EMA) issued its latest product information warning for Vaxzevria (Astra Zeneca) and COVID-19 Vaccine Janssen (Johnson and Johnson) on January 14 2022.
The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) recommended a change to the product information for both vaccines “to include a warning to raise awareness among healthcare professionals and people receiving the vaccines of very rare cases of transverse myelitis (TM) reported following vaccination. TM has also been added as an adverse reaction of unknown frequency.”
“TM is a rare neurological condition characterised by an inflammation of one or both sides of the spinal cord. It can cause weakness in the arms or legs, sensory symptoms (such as tingling, numbness, pain or loss of pain sensation) or problems with bladder or bowel function.”
“The PRAC has concluded that a causal relationship between these two vaccines and transverse myelitis is at least a reasonable possibility.”
The EMA’s safety committee issued three advice updates in 2021 relating to Astra Zeneca.
On June 11 2021, the PRAC advised against use in people with history of capillary leak syndrome and concluded that capillary leak syndrome should be added to the product information as a new side effect of the vaccine, together with a warning to raise awareness among healthcare professionals and patients of this risk.
On May 21 2021, the EMA’s human medicines committee (CHMP) recommended that healthcare professionals ‘must not give Vaxzevria to anyone who has had blood clots with low blood platelets (thrombosis with thrombocytopenia syndrome, TTS) after receiving the vaccine.’
It advised ‘urgent medical attention immediately’ if experiencing shortness of breath, chest pain, leg swelling, leg pain, persistent abdominal pain, neurological symptoms, such as severe and persistent headaches, blurred vision, confusion or seizures, unusual skin bruising or pinpoint round spots beyond the site of the injection.
On April 7 2021 the PRAC issued advice reminding healthcare professionals and people receiving the vaccine ‘to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within 2 weeks of vaccination.’
At this point, most of the cases reported had occurred in women under 60 years of age within 2 weeks of vaccination, according to the EMA.
“The PRAC noted that the blood clots occurred in veins in the brain (cerebral venous sinus thrombosis, CVST) and the abdomen (splanchnic vein thrombosis) and in arteries, together with low levels of blood platelets and sometimes bleeding.
“The Committee carried out an in-depth review of 62 cases of cerebral venous sinus thrombosis and 24 cases of splanchnic vein thrombosis reported in the EU drug safety database (EudraVigilance) as of 22 March 2021, 18 of which were fatal.”